Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.42 - $0.57 $1 - $1
3 New
3 $0
Q4 2022

Feb 13, 2023

BUY
$2.03 - $4.28 $6 - $12
3 New
3 $0
Q4 2020

Feb 09, 2021

SELL
$15.77 - $19.03 $1,624 - $1,960
-103 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$16.59 - $24.79 $1,708 - $2,553
103 New
103 $2,000
Q2 2020

Aug 10, 2020

SELL
$16.86 - $23.44 $61,572 - $85,602
-3,652 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$14.47 - $27.96 $21,907 - $42,331
1,514 Added 70.81%
3,652 $65,000
Q4 2019

Feb 04, 2020

BUY
$15.87 - $23.12 $31,549 - $45,962
1,988 Added 1325.33%
2,138 $47,000
Q2 2019

Aug 01, 2019

SELL
$31.0 - $36.3 $6,200 - $7,259
-200 Reduced 57.14%
150 $0
Q1 2019

May 20, 2019

BUY
$31.58 - $46.35 $3,158 - $4,635
100 Added 40.0%
350 $12,000
Q4 2018

Feb 15, 2019

SELL
$30.43 - $56.65 $19,596 - $36,482
-644 Reduced 72.04%
250 $8,000
Q2 2018

Jul 27, 2018

BUY
$46.25 - $104.45 $39,035 - $88,155
844 Added 1688.0%
894 $45,000
Q1 2018

Apr 23, 2018

SELL
$57.4 - $108.44 $2,870 - $5,422
-50 Reduced 50.0%
50 $0
Q4 2017

Feb 08, 2018

BUY
$23.02 - $60.5 $2,302 - $6,050
100
100 $6,000

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $154M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.